🟢 Beam Therapeutics is trading 5.2% up in pre-market with no clear catalyst identified

Beam Therapeutics is trading at $27.00, up 5.18%, with no confirmed company-specific catalyst identified.

• No clear company-specific announcement dated October 6 surfaced in searched news. The latest identified company release was September 8 clinical data on BEAM-302, not a confirmed catalyst for this pre-market move.
• Major indices were higher, but none gained more than 0.5%. Available evidence does not establish why shares are higher.